Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q7118227> ?p ?o }
Showing triples 1 to 32 of
32
with 100 triples per page.
- Q7118227 subject Q8707914.
- Q7118227 abstract "PARP inhibitors are a group of pharmacological inhibitors of the enzyme poly ADP ribose polymerase (PARP). They are developed for multiple indications; the most important is the treatment of cancer. Several forms of cancer are more dependent on PARP than regular cells, making PARP an attractive target for cancer therapy. PARP inhibitors appear to improve progression-free survival in women with recurrent platinum-sensitive ovarian cancer, as evidenced mainly by olaparib added to conventional treatment.In addition to their use in cancer therapy, PARP inhibitors are considered a potential treatment for acute life-threatening diseases, such as stroke and myocardial infarction, as well as for long-term neurodegenerative diseases.".
- Q7118227 wikiPageExternalLink GKH215F5.
- Q7118227 wikiPageExternalLink www.parp-inhibitors.com.
- Q7118227 wikiPageWikiLink Q12152.
- Q7118227 wikiPageWikiLink Q12202.
- Q7118227 wikiPageWikiLink Q128406.
- Q7118227 wikiPageWikiLink Q14878377.
- Q7118227 wikiPageWikiLink Q14907732.
- Q7118227 wikiPageWikiLink Q172341.
- Q7118227 wikiPageWikiLink Q1755122.
- Q7118227 wikiPageWikiLink Q17710375.
- Q7118227 wikiPageWikiLink Q17853272.
- Q7118227 wikiPageWikiLink Q18046302.
- Q7118227 wikiPageWikiLink Q180507.
- Q7118227 wikiPageWikiLink Q181257.
- Q7118227 wikiPageWikiLink Q218447.
- Q7118227 wikiPageWikiLink Q227339.
- Q7118227 wikiPageWikiLink Q260286.
- Q7118227 wikiPageWikiLink Q3658562.
- Q7118227 wikiPageWikiLink Q3907241.
- Q7118227 wikiPageWikiLink Q427492.
- Q7118227 wikiPageWikiLink Q4634111.
- Q7118227 wikiPageWikiLink Q664846.
- Q7118227 wikiPageWikiLink Q7083106.
- Q7118227 wikiPageWikiLink Q731938.
- Q7118227 wikiPageWikiLink Q7376558.
- Q7118227 wikiPageWikiLink Q7843332.
- Q7118227 wikiPageWikiLink Q7919041.
- Q7118227 wikiPageWikiLink Q8707914.
- Q7118227 comment "PARP inhibitors are a group of pharmacological inhibitors of the enzyme poly ADP ribose polymerase (PARP). They are developed for multiple indications; the most important is the treatment of cancer. Several forms of cancer are more dependent on PARP than regular cells, making PARP an attractive target for cancer therapy.".
- Q7118227 label "PARP inhibitor".